Half-Life and Doom are remembered as the defining games of the FPS golden era, but one vicious and vivid shooter deserves the ...

SAN FRANCISCO and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Guggenheim ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...

The climate has changed in the past, long before humans, so how do scientists know our recent warming is caused by man?

Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment ...

Farmers Market holds Kids Day Kids Day at the Cardiff Farmers Market starts at 10 a.m. Feb. 1 at 3333 Manchester Ave. The ...

North Coast Repertory Theatre is located at 987 Lomas Santa Fe Drive, Solana Beach. Tickets are $50 with discounts for ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...

Highlights Two abstracts on Clarity's diagnostic COBRA and CLARIFY trials with 64Cu-SAR-bisPSMA have been accepted for presentation at the American Society of Clinical Oncology Genitourinary Cancers ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.31 billion and an impressive gross profit margin of 72.39%, has announced that its new drug applications ...